Class-wide REMS for extended-release and long-acting opioids: Potential impact on pharmacies

Although the changing requirements for prescribing ER/LA opioids will not have a direct effect on pharmacist workflow, the pharmacist-patient interaction remains critical for overall risk reduction with this class of medication.